Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Iradimed (IRMD) Tax Provisions (2016 - 2026)

Iradimed has reported Tax Provisions over the past 14 years, most recently at $2.0 million for Q1 2026.

  • Quarterly Tax Provisions rose 55.09% to $2.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Mar 2026, up 26.62% year-over-year, with the annual reading at $5.9 million for FY2025, 16.66% up from the prior year.
  • Tax Provisions was $2.0 million for Q1 2026 at Iradimed, up from $1.3 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $2.6 million in Q4 2023 and troughed at $573295.0 in Q1 2022.
  • The 5-year median for Tax Provisions is $1.3 million (2025), against an average of $1.3 million.
  • Year-over-year, Tax Provisions soared 232.19% in 2022 and then crashed 53.31% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $1.0 million in 2022, then skyrocketed by 148.93% to $2.6 million in 2023, then crashed by 53.31% to $1.2 million in 2024, then increased by 12.65% to $1.3 million in 2025, then soared by 44.66% to $2.0 million in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Tax Provisions are $2.0 million (Q1 2026), $1.3 million (Q4 2025), and $1.7 million (Q3 2025).